Westport_logo.jpg
Westport Reports Second Quarter 2024 Financial Results and Revises Segment Reporting
August 13, 2024 17:00 ET | Westport Fuel Systems Inc.
VANCOUVER, British Columbia, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Westport Fuel Systems Inc. (“Westport") (TSX:WPRT / Nasdaq:WPRT), a leading supplier of advanced alternative fuel systems and...
BEAM-Logo-Color and Black-Large-576x375.png
Beam Global Announces Record Second Quarter 2024 Operating Results
August 13, 2024 16:31 ET | Beam Global
SAN DIEGO, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Beam Global, (Nasdaq: BEEM), (the “Company”), a provider of innovative and sustainable infrastructure solutions for the electrification of transportation...
INSP_Logo_withPalm_Black_CMYK (1).png
Inspirato Announces Second Quarter Results and Closing of $10 Million Investment Agreement with One Planet Group LLC
August 13, 2024 16:30 ET | Inspirato Incorporated
DENVER, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Inspirato Incorporated (“Inspirato” or the “Company”) (NASDAQ: ISPO), the innovative luxury travel club, today announced its 2024 second quarter financial...
BioCardia-Final-Logo-2016-JPEG.jpg
BioCardia Reports Second Quarter 2024 Business Highlights and Financial Results
August 13, 2024 16:30 ET | BioCardia, Inc.
SUNNYVALE, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...
Syntec-Optics_Logo_Press-Release_3.png
Syntec Optics (Nasdaq: OPTX) to Host Conference Call to Discuss Financial Results and Business Update
August 13, 2024 16:30 ET | Syntec Optics
ROCHESTER, NEW YORK, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Syntec Optics, a leading provider of mission-critical optics for scientific and technical instruments and equipment OEMs in diverse defense,...
image001.png
Sutro Biopharma Reports Second Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones
August 13, 2024 16:30 ET | Sutro Biopharma, Inc.
- Sutro will present updated data from the ongoing Phase 1b study of luvelta in combination with bevacizumab in a poster presentation at ESMO 2024; expansion study is ongoing with data expected in the...
SB LOGO FULL gradient copy.jpg
Springbig Reports Second Quarter 2024 Financial Results
August 13, 2024 16:30 ET | springbig
Second consecutive quarter with positive Adjusted EBITDA*, increasing year-to-date Adjusted EBITDA* to $0.5 million, representing a $3.0 million year-on-year improvement2% quarter-over-quarter...
Logo.jpg
Elicio Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
August 13, 2024 16:30 ET | Elicio Therapeutics Inc.
• AMPLIFY-7P Phase 1 preliminary disease-free (“DFS”) survival demonstrates strong correlation between T cell response and reduced risk of progression or death• AMPLIFY-7P Phase 1 data presented at...
Cidara.png
Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
August 13, 2024 16:29 ET | Cidara Therapeutics, Inc.
SAN DIEGO, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate...
Logo 1200x628.jpg
CytoSorbents Reports Second Quarter 2024 Financial and Operational Results
August 13, 2024 16:19 ET | CytoSorbents
New CFO Peter J. Mariani to succeed retiring CFO Kathleen P. BlochOn track for DrugSorb™-ATR U.S. FDA De Novo and Health Canada marketing submissions this quarterIn Q2 2024, increased product sales by...